まとめ
インスリン依存型糖尿病患者のリンパ球は,インスリン腫細胞を攻撃し,疾患の潜在的自己免疫的基盤を示唆する. この細胞の攻撃は,実験室で観察され,補完体の活性化には関わらなかった.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 細胞生物学 細胞生物学
背景:
- インスリン依存性糖尿病 (IDDM) は,複雑な自己免疫疾患である.
- IDDMにおけるβ細胞破壊の特定のメカニズムは,完全に解明されていません.
- 臓のβ細胞に対する自己攻撃が主要な仮説である.
研究 の 目的:
- IDDM患者からのリンパ球がヒトインスリンローマ細胞に及ぼす細胞毒性の効果を調査する.
- リンパ球媒介性インスリン腫細胞破壊におけるコンプリメントの役割を決定する.
主な方法:
- IDDM患者のリンパ球と,ヒトインスリノーマ細胞を持つ正常な個体からのリンパ球のインビトロ共培養.
- リンパ球の細胞結合と細胞毒性の評価.
- 細胞破壊における補完体の関与の評価.
主要な成果:
- IDDM患者からのリンパ球は,ヒトインスリノーマ細胞に対する有意なサイトアヘレンスとサイト毒性を示した.
- 正常な個体からのリンパ球は,インスリン腫細胞に最小限の効果を示した.
- 補充は,観察されたインスリン腫細胞破壊には関与しませんでした.
結論:
- この発見は,IDDMが臓のβ細胞に対する自己攻撃を伴うという仮説を裏付けている.
- リンパ球媒介による細胞毒性は,IDDMにおけるβ細胞破壊において重要な役割を果たす可能性があります.
- この自己免疫反応を標的とした治療戦略を探るため,さらなる研究が必要である.
さらに関連する動画
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
10:03Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
関連する概念動画
Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Insipidus I: Introduction
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
